Moxeza

Product manufactured by Alcon Laboratories, Inc.

Application Nr Approved Date Route Status External Links
NDA022428 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Moxeza ® Solution Is Indicated For The Treatment Of Bacterial Conjunctivitis Caused By Susceptible Strains Of The Following Organisms: Aerococcus Viridans* Corynebacterium Macginleyi* Enterococcus Faecalis* Micrococcus Luteus* Staphylococcus Arlettae* Staphylococcus Aureus Staphylococcus Capitis Staphylococcus Epidermidis Staphylococcus Haemolyticus Staphylococcus Hominis Staphylococcus Saprophyticus* Staphylococcus Warneri* Streptococcus Mitis* Streptococcus Pneumoniae Streptococcus Parasanguinis* Escherichia Coli* Haemophilus Influenza Klebsiella Pneumoniae* Propionibacterium Acnes Chlamydia Trachomatis* *efficacy For This Organism Was Studied In Fewer Than 10 Infections. Moxeza ® Solution Is A Topical Fluoroquinolone Anti-Infective Indicated For The Treatment Of Bacterial Conjunctivitis Caused By Susceptible Strains Of The Following Organisms: Aerococcus Viridans*, Corynebacterium Macginleyi*, Enterococcus Faecalis*, Micrococcus Luteus*, Staphylococcus Arlettae*, Staphylococcus Aureus, Staphylococcus Capitis, Staphylococcus Epidermidis, Staphylococcus Haemolyticus, Staphylococcus Hominis, Staphylococcus Saprophyticus*, Staphylococcus Warneri*, Streptococcus Mitis*, Streptococcus Pneumoniae, Streptococcus Parasanguinis*, Escherichia Coli*, Haemophilus Influenzae, Klebsiella Pneumoniae*, Propionibacterium Acnes, Chlamydia Trachomatis* *efficacy For This Organism Was Studied In Fewer Than 10 Infections. (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Moxifloxacin Hydrochloride MOXIFLOXACIN HYDROCHLORIDE ZINC3826253

Comments